Investigational Product Storage Records: A Compliance Checklist
Investigational product storage records prove an IMP was held under its approved conditions for the whole time it was at site. This guide sets out the storage record set, why it fails at inspection, ALCOA+ for temperature data, the excursion workflow, and a compliance checklist grouped by lifecycle stage.
CAPA Example: A Clinical Trial Deviation Walked Through Step by Step
A CAPA example shows what corrective and preventive action looks like in practice: one quality event, traced from detection to verified closure. This guide walks a single clinical trial deviation through all seven stages, with dates, named artefacts, and the judgement calls a QA Lead has to make along the way.
Drug Accountability Logs: What Auditors Actually Check
The drug accountability log is where an inspector goes to prove investigational product was controlled. This guide walks the receipt-to-destruction chain, the ALCOA+ rules, reconciliation, and the common findings auditors write, with the control that prevents each.
What is Inspection Readiness in Clinical Trials and How Does It Work Across a CRDC Network?
Inspection readiness in clinical research is the condition that exists when every site within a research network can produce complete, accurate, and current evidence of research activity at any point in the study lifecycle, without requiring emergency preparation, manual record reconstruction, or document requests sent to individual teams. This guide explains what inspection readiness means […]
How to Build a CAPA Action Plan That Actually Addresses Root Cause?
The majority of CAPA management software action plans fail during the design stage rather than the implementation stage. Teams complete the actions, upload the evidence, and meet the due dates. The QA Lead approves the record, the CAPA closes, and three months later the same quality event appears again at the same site or another […]
CAPA Management Software in Clinical Research: The Complete Guide
Quality failures in clinical research rarely surface without early warning signs. Delegation logs remain unsigned for weeks. Investigational products get dispensed outside approved storage windows. The same data entry discrepancy appears again during monitoring, even after previous corrective steps. Every issue leads to documentation, internal discussions, and sometimes formal findings. In many cases, identical operational […]
Clinical Research Audits: Types, Process, Checklist, and Audit Readiness Guide
Every clinical trial moves through a series of controlled activities. Each stage adds data, decisions, documentation, and operational responsibility that directly affect participant safety, protocol compliance, and data integrity. Unfortunately, completed study activity alone does not confirm compliant execution. Every critical step requires confirmation of correct execution, clear documentation, proper review, and controlled oversight. Clinical […]
What is the Best Way to Manage Deviations in Clinical Research?
Notably, a protocol deviation refers to any departure from the approved study protocol, whether planned or unplanned. It may involve missed procedures, incorrect dosing, out-of-window visits, or incomplete documentation. Each deviation must be assessed for its impact on participant safety and data integrity, in line with GCP expectations. In practice, most deviations do not originate […]
CTMS VS QMS for Clinical Trial Data Management
Clinical trials operate across two distinct responsibilities. CTMS supports study execution through participant management, scheduling, and site coordination. QMS supports quality and compliance through document control, training management, deviation tracking, and CAPA. Each system addresses a specific need within clinical trial data management. Clinical research teams often assume that a traditional Clinical Trial Management System […]
What is Pharmacovigilance in Quality Management?
The World Health Organization defines pharmacovigilance as the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other medicine-related problem. Notably, Pharmacovigilance scope requires structured processes, controlled documentation, and continuous oversight, which directly aligns with quality management systems. It is essential to understand how pharmacovigilance operates within quality […]
